Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HTX Energy Fund was a Houston-based hedge fund focused on the energy sector, founded and managed by Kevin Comcowich. The fund operated from approximately 2012 until Comcowich's retirement from the fund in 2014. While the fund itself was primarily focused on energy investments, it is frequently cited in the life sciences sector due to the subsequent roles of its leadership, particularly Kevin Comcowich, who served as the Chairman and interim CEO of the agricultural biotechnology company Arcadia Biosciences (RKDA). The fund's legacy is primarily linked to the financial and executive leadership its founders brought to the biotech and high-technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HTX Energy Fund.